Ideas to action: independent research for global prosperity
Women's Underrepresentation in IFI Leadership
November 27, 2023
EU-Africa Strategy: State of Play
November 24, 2023
Developing an Omni-Channel Deployment Strategy for COVID-19 Oral Antivirals
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Testimony on Modernizing Development Assistance
December 13, 2022
On December 13th 2022, CGD Senior Fellow Prashant Yadav appeared before the House Foreign Affairs Subcommittee on International Development, International Organizations, and Global Corporate Social Impact at a hearing titled “Modernizing International Development Assistance: Opportunities and Challe...
Understanding the Costs and Benefits of Investing in Laboratory Systems in African Countries
November 10, 2022
Laboratories are fundamental components of health systems, but investments in strengthening laboratory systems are often inconsistent and inadequate in African countries. This paper qualitatively establishes the complex costs and benefits of strengthening laboratory capacity and systems within and a...
Rapid and Equitable Access to Medical Countermeasures: Lessons, Landscape, and Near-Term Recommendations
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
Policy Actions for the US Government to Accelerate Access to Oral Antivirals for COVID-19 in Low- and Middle-Income Countries
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
Expanding Emergency Vaccine Manufacturing Capacity in Latin America and the Caribbean
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
Decentralized Purchasing of Essential Medicines and Its Impact on Availability, Prices, and Quality: A Review of Current Evidence
January 28, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), public sector supply chain performance is far from optimal, resulting in frequent stockouts at healt...